Seethal Madhavarapu, MD
Sports Medicine · Oklahoma City, OKNPI 1376563163
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Trice Medical, Inc. at 38.4% of the total. Reporting peaked in 2022 at $245 and has fallen 89.8% since, to $25 in 2025. That places this record below the midpoint for sports medicine clinicians in OK, where the typical reported total is $928.
Across 17 payments — averaging $28.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trice Medical, Inc.$184
- ERMI LLC$61
- Amgen$55
- Pacira Therapeutics, Inc.$32
- Fidia Pharma USA Inc.$29
- Radius Health, Inc.$28
- plus $91 from 4 others
What the payments were for
- Food & beverage$480100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trice Medical, Inc. | 1 | $184 |
| ERMI LLC | 1 | $61 |
| Amgen | 4 | $55 |
| Pacira Therapeutics, Inc. | 2 | $32 |
| Fidia Pharma USA Inc. | 2 | $29 |
| Radius Health, Inc. | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Bioventus LLC | 2 | $24 |
| Medtronic | 1 | $23 |
| Avanos Medical | 1 | $19 |
How this compares
$480 in reported general payments places this provider in the 30th percentile of 55 sports medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 44 | $857 |
| Ibuprofen | 43 | $428 |
| Gabapentin | 32 | $241 |
| Meloxicam | 76 | $211 |
| Naproxen | 14 | $177 |
| Cyclobenzaprine Hcl | 15 | $109 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Oklahoma City
- Michael MaxtedOklahoma City$23K
- George GhataOklahoma City$7K
- Douglas RowlesOklahoma City$6K
- Charles PasqueOklahoma City$3K
- Blake MiddletonOklahoma City$3K
- Timothy GeibOklahoma City$2K
- Gene MuseOklahoma City$348
- Anthony CruseOklahoma City$213
- Antoine JabbourTulsa$55K
- John GlomsetNorman$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.